27 November 2022 - A treatment that could allow advanced prostate cancer patients to avoid chemotherapy and live longer has arrived – but there’s a catch.
Australian researchers and charity organisations like Movember were integral in the development of Lutetium PSMA (Lu-PSMA) – but the treatment is not yet approved or funded in the country.